Projects per year
Fingerprint
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Grants
- 15 Finished
-
Diversity-focused Montefiore Einstein Clinical Oncology Training Program in the Bronx
Verma, A. K. (PI) & Saenger, Y. M. (CoPI)
4/1/23 → 3/31/24
Project: Research project
-
Therapeutic targeting of IRAK4 in MDS
Verma, A. K. (PI) & Starczynowski, D. T. (CoPI)
9/2/22 → 7/31/23
Project: Research project
-
STAT3 inhibition as a therapeutic strategy against MDS stem cells
Verma, A. K. (PI) & Steidl, U. G. (CoPI)
National Heart, Lung, and Blood Institute
7/23/19 → 6/30/23
Project: Research project
-
Cooperative Research Agreements Related to the World Trade Center Health Program (U01)
Verma, A. K. (PI)
1/1/19 → 6/30/20
Project: Research project
-
Therapeutic targeting of MDS stem cells
Steidl, U. G. (PI) & Verma, A. K. (CoPI)
8/20/18 → 6/30/22
Project: Research project
-
A blueprint for pursuing therapeutic interventions and early phase clinical trials in clonal haematopoiesis
Haque, T., Shastri, A., Desai, P., Xie, Z., Hammond, D., King, Z., Kishtagari, A., Madanat, Y. F., Abaza, Y., Silver, A. J., Singh, A., Borate, U. M., Heimlich, J. B., Slosky, D. A., Bolton, K. L., Patnaik, M. S., Bick, A. G., Verma, A. K., Jaiswal, S. & Steensma, D. P. & 1 others, , Feb 2025, In: British Journal of Haematology. 206, 2, p. 416-427 12 p.Research output: Contribution to journal › Review article › peer-review
Open Access4 Scopus citations -
Adding the FcRn antagonist efgartigimod for the prevention of IgG-mediated complications in the peri-transplant period
Cooper, D. L., Verceles, J. A., Kheradmand, T., Paroder, M., Lombardo, A., de Castro, A., Browne, R., Konopleva, M., Moavero, B., Goldfinger, M., Mantzaris, I., Kornblum, N., Sica, R. A., Shastri, A., Shapiro, L. C., Peeke, S. Z., Gupta, R., Gritsman, K., Feldman, E. J. & Verma, A., Oct 2025, In: Transfusion. 65, 10, p. 1978-1981 4 p.Research output: Contribution to journal › Article › peer-review
-
Advancing drug development in myelodysplastic syndromes
Mina, A., McGraw, K. L., Cunningham, L., Kim, N., Jen, E. Y., Calvo, K. R., Ehrlich, L. A., Aplan, P. D., Garcia-Manero, G., Foran, J. M., Garcia, J. S., Zeidan, A. M., DeZern, A. E., Komrokji, R., Sekeres, M. A., Scott, B., Buckstein, R., Tinsley-Vance, S., Verma, A. & Wroblewski, T. & 2 others, , Mar 11 2025, In: Blood Advances. 9, 5, p. 1095-1104 10 p.Research output: Contribution to journal › Review article › peer-review
Open Access4 Scopus citations -
A germline FLT3 variant in aplastic anemia
Amaeshi, L. C., Sofianidi, A. A., Shastri, A., Goldfinger, M., Konopleva, M., Verma, A. K., Chaitowitz, M. & Mantzaris, I., Dec 2025, In: Biomarker Research. 13, 1, 4.Research output: Contribution to journal › Letter › peer-review
Open Access -
Assessing the performance of the Iceland screens, treats, or prevents multiple myeloma (iStopMM) model in a multicultural Bronx cohort: implications for monoclonal gammopathy of undetermined significance risk stratification
Gor, R., Shivakumar, J., Surana, P., Wei, J., Murakhovskaya, I., Goldfinger, M., Kornblum, N., Shapiro, L., Shastri, A., Gupta, R., Levitz, D., Konopleva, M., Feldman, E., Gritsman, K., Sica, R. A., Mantzaris, I., Verma, A., Cooper, D., Janakiram, M. & Shah, N., Dec 2025, In: Blood cancer journal. 15, 1, 140.Research output: Contribution to journal › Article › peer-review
Open Access